JPH07121957B2 - リポペプチド誘導体 - Google Patents

リポペプチド誘導体

Info

Publication number
JPH07121957B2
JPH07121957B2 JP3054789A JP5478991A JPH07121957B2 JP H07121957 B2 JPH07121957 B2 JP H07121957B2 JP 3054789 A JP3054789 A JP 3054789A JP 5478991 A JP5478991 A JP 5478991A JP H07121957 B2 JPH07121957 B2 JP H07121957B2
Authority
JP
Japan
Prior art keywords
compound
salt
independently
alkyl
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP3054789A
Other languages
English (en)
Japanese (ja)
Other versions
JPH04217699A (ja
Inventor
エル．ハモンド ミルトン
エム．バルコヴェク ジェームス
イー．シュワルツ ロバート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPH04217699A publication Critical patent/JPH04217699A/ja
Publication of JPH07121957B2 publication Critical patent/JPH07121957B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP3054789A 1990-03-19 1991-03-19 リポペプチド誘導体 Expired - Fee Related JPH07121957B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49519990A 1990-03-19 1990-03-19
US495199 1990-03-19

Publications (2)

Publication Number Publication Date
JPH04217699A JPH04217699A (ja) 1992-08-07
JPH07121957B2 true JPH07121957B2 (ja) 1995-12-25

Family

ID=23967674

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3054789A Expired - Fee Related JPH07121957B2 (ja) 1990-03-19 1991-03-19 リポペプチド誘導体

Country Status (11)

Country Link
EP (1) EP0448343A3 (no)
JP (1) JPH07121957B2 (no)
KR (1) KR910016771A (no)
AU (1) AU7358591A (no)
CA (1) CA2038497A1 (no)
FI (1) FI911308A (no)
IE (1) IE910893A1 (no)
IL (1) IL97347A0 (no)
NO (1) NO911065L (no)
PT (1) PT97043A (no)
ZA (1) ZA911978B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430018A (en) * 1991-10-17 1995-07-04 Merck & Co., Inc. Cyclohexapeptide with basic nitrogen containing alkylamide groups
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
NZ247149A (en) * 1992-03-19 1996-10-28 Lilly Co Eli Cyclic peptide antifungal agents and compositions thereof
EP0612923B1 (en) * 1993-02-23 1999-07-21 Hitachi, Ltd. Vortex flow blower and vane wheel therefor
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
JP2002528388A (ja) 1998-08-20 2002-09-03 イーライ リリー アンド カンパニー 環改変された環状ペプチドアナログ
WO2000051564A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
IL145187A0 (en) 1999-03-03 2002-06-30 Lilly Co Eli Echinocandin/carbohydrate complexes
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030844A1 (en) * 1979-12-13 1981-06-24 Eli Lilly And Company Recovery process for A-30912 antibiotics

Also Published As

Publication number Publication date
ZA911978B (en) 1991-12-24
NO911065D0 (no) 1991-03-18
AU7358591A (en) 1993-01-28
IL97347A0 (en) 1992-05-25
EP0448343A2 (en) 1991-09-25
FI911308A0 (fi) 1991-03-18
EP0448343A3 (en) 1992-01-22
CA2038497A1 (en) 1991-09-20
NO911065L (no) 1991-09-20
FI911308A (fi) 1991-09-20
PT97043A (pt) 1991-10-31
IE910893A1 (en) 1991-09-25
KR910016771A (ko) 1991-11-05
JPH04217699A (ja) 1992-08-07

Similar Documents

Publication Publication Date Title
US5330973A (en) Lipopeptide derivatives
JPH07121957B2 (ja) リポペプチド誘導体
WO2010075416A1 (en) Antibiotic compositions for the treatment of gram negative infections
US5310726A (en) Lipopeptide compounds
US5741775A (en) Cyclohexapeptidyl aminoalkyl ethers
US5386009A (en) Lipopeptide derivatives
US5369093A (en) Lipopeptide derivatives
US5386010A (en) Lipopeptide compounds
EP0535959B1 (en) Cyclohexapeptidyl propanolamine compounds
US5428009A (en) Lipopeptide derivatives
EP0539088B1 (en) Echinocandin b derivative
US5385884A (en) Lipopeptide derivatives
US5399552A (en) Antibiotic peptides bearing aminoalkylthioether moieties
CA2057711C (en) Antibiotic agent
US5914313A (en) 1- 4-hydroxy-5-aminoethyloxy-N2 -(10,12-dimethyl-1-oxotetradecyl)ornithine!-5-(3-hydroxyglutamine)-6-(3-hydroxyproline)echinocandin B, other aminoalkyl derivatives and salts thereof
US5348940A (en) Cyclohexapeptidyl hydroxypropionitrile compounds
EP0405998A1 (en) Antibiotic agents
US5430018A (en) Cyclohexapeptide with basic nitrogen containing alkylamide groups

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19960612